What Is a Lymph Node Biopsy and How Is It Done?

A lymph node biopsy is a procedure that removes a small amount of tissue, or sometimes an entire lymph node, so a pathologist can examine it under a microscope and determine what is causing it to swell or look abnormal. It ranges from a quick needle stick in a doctor’s office to a short surgical procedure under general anesthesia, depending on what your doctor needs to find out. The method chosen depends on the suspected diagnosis, the node’s location, and how much tissue the lab requires to give a clear answer.

Why Doctors Order a Lymph Node Biopsy

Lymph nodes are small, bean-shaped organs scattered throughout your body that filter fluid and help fight infection. Most of the time, a swollen lymph node means your immune system is responding to a cold, a dental infection, or another routine illness. A biopsy enters the picture when a node stays enlarged longer than expected, keeps growing, feels unusually hard or fixed in place, or shows up in a location that raises concern.

Certain warning signs push doctors toward a biopsy sooner rather than later. A swollen node just above the collarbone, for instance, is strongly associated with malignancy and almost always warrants further investigation.¹ Other features linked to cancer include a node that feels stuck to the tissue underneath it, difficulty breathing, fever without an obvious infection, and imaging that shows the node has lost its normal internal structure. The risk of malignancy also climbs when multiple levels of neck lymph nodes are involved or when nodes in the lower neck and supraclavicular area are affected.²

Size alone is not a reliable guide. A large node can be entirely benign, and a small one can harbor cancer. What matters more is the combination of size, duration, location, and additional symptoms. Persistent enlargement in the absence of a clear infectious cause is generally treated as a red flag, especially in specialist settings where the pre-test likelihood of cancer is higher.¹

Fine-Needle Aspiration

Fine-needle aspiration, often called FNA or FNAC, is the least invasive form of lymph node biopsy. A thin needle, thinner than the kind used for routine blood draws, is inserted into the lymph node, and a syringe is used to suction out a small cluster of cells. The whole thing takes minutes, usually without sedation, and you can go back to normal activities almost immediately. Results from the cytopathologist can come back quickly, sometimes within the same day.³

FNA works well as a first-line screening tool. It can identify infections like tuberculosis, detect cancer that has spread from another organ into a lymph node, and flag some types of lymphoma. It is routinely used for cervical lymph nodes when a head-and-neck cancer is suspected.⁴ That said, FNA has a clear limitation: because it collects individual cells rather than an intact piece of tissue, it often cannot provide enough information to classify the exact subtype of a lymphoma or confirm certain other diagnoses. The initial needle sample frequently needs follow-up testing, such as special stains or flow cytometry, to pin down a specific diagnosis.⁴ Think of FNA as an efficient way to sort patients into “probably benign,” “suspicious,” or “definitely needs more tissue” categories.

Core Needle Biopsy

When FNA does not give enough information, a core needle biopsy is the next step up. This technique uses a slightly larger, spring-loaded needle that cuts a thin cylinder of tissue from the node. The tissue sample preserves the node’s internal architecture, which matters when pathologists need to see how cells are arranged relative to each other rather than just what individual cells look like.

The procedure is typically done with local anesthesia and ultrasound or CT guidance. An interventional radiologist inserts a guide needle into the node, then fires the core biopsy needle through it multiple times to collect several tissue strips from different areas of the node.⁵ Taking samples from different regions reduces the chance of missing the abnormal area. The needle gauges used are typically in the 14 to 18 range, still small enough that stitches are rarely needed.⁶

Core needle biopsy is especially useful when lymphoma is suspected, because it provides enough tissue architecture for the pathologist to begin subtyping. It is also a practical option for nodes that are deep inside the body, where a full surgical excision would be riskier. The trade-off is that the diagnostic yield, while good, is not quite as high as surgical excision for complex lymphomas that require a large, intact tissue sample.

Surgical Excisional Biopsy

Excisional biopsy means removing the entire lymph node through a small incision. This gives the pathologist the most tissue to work with and is considered the gold standard for diagnosing lymphomas, because the full architecture of the node is preserved intact. It is usually done under local or general anesthesia, depending on the node’s depth and location. Recovery takes a bit longer than needle-based methods, but the procedure itself is straightforward for superficial nodes in the neck, armpit, or groin.

Surgeons almost always prefer excisional over incisional biopsy, where only part of a node is removed. Incisional biopsy carries a higher risk of complications, including lymph fluid leaking into the wound, infection, and fistula formation. This risk is particularly pronounced when the underlying cause turns out to be tuberculosis, making incisional biopsy effectively contraindicated in that scenario.⁷ A 12-year review from a single center found no serious surgical complications in any of their excisional biopsy patients.⁷

Sentinel Lymph Node Biopsy

Sentinel lymph node biopsy is a specialized procedure used mainly in cancer staging. Rather than sampling a node that is already swollen, the goal is to find and remove the first node that drains the area around a tumor. If cancer cells have started to spread through the lymphatic system, they would reach this “sentinel” node before any others. Checking it tells surgeons whether the cancer has begun to move beyond its original site.

The technique involves injecting a radioactive tracer, a blue dye, or both near the tumor before surgery. The tracer travels through the lymph channels and collects in the sentinel node, which the surgeon then locates using a handheld gamma probe or by looking for the blue stain.⁸ The most commonly used radioactive tracers are technetium-99m-labeled colloids, and research shows that different formulations of these tracers perform comparably well in detecting the sentinel node.⁹

Sentinel node biopsy has changed cancer treatment dramatically, especially for breast cancer and melanoma. Before it existed, surgeons often removed large groups of lymph nodes to check for spread, a procedure that carried significant risk of chronic arm swelling (lymphedema) and other side effects. Now, if the sentinel node is negative, doctors can spare the remaining nodes entirely.

When Sentinel Node Biopsy Can Be Skipped

Recent guidelines from the American Society of Clinical Oncology have gone even further, recommending that certain breast cancer patients skip sentinel node biopsy altogether. Specifically, postmenopausal women aged 50 or older with small, low-to-intermediate grade, hormone-receptor-positive tumors and a normal preoperative axillary ultrasound may not need it if they are having breast-conserving surgery.¹⁰ For those who do have the sentinel biopsy and find one or two positive nodes, the updated guidance allows skipping a more extensive lymph node dissection if radiation therapy will cover the area. The guidelines also support offering sentinel biopsy in situations that were once considered off-limits, including larger tumors, patients who are pregnant, obese, or male, and those who have had prior breast or axillary surgery.¹⁰

How Imaging Guides the Needle

Most lymph node biopsies today are performed under some form of image guidance, which lets the doctor see the node in real time and steer the needle accurately into it. Ultrasound is the most common tool for nodes near the surface, such as those in the neck, armpit, or groin. It is painless, involves no radiation, and gives the proceduralist a live picture of where the needle tip is sitting relative to the node and any nearby blood vessels. When performed by a skilled operator, ultrasound-guided biopsy of cervical lymph nodes offers a high diagnostic yield and can save the patient from more invasive surgical procedures.¹¹

For lymph nodes deep inside the chest, a technique called endobronchial ultrasound, or EBUS, allows doctors to reach mediastinal nodes without opening the chest. A bronchoscope fitted with an ultrasound probe is threaded through the airway, and a needle passes through the bronchoscope wall to sample nodes that sit alongside the major airways. In a prospective evaluation of this approach, all targeted lymph nodes were correctly located, and about nine out of ten biopsied nodes gave tissue samples adequate for diagnosis.¹² CT-guided biopsy is another option for deep nodes, particularly those in the abdomen or pelvis that cannot be reached by ultrasound or EBUS.

What Happens to the Sample in the Lab

Once tissue or cells reach the pathology laboratory, the analysis depends on what diagnosis is being considered. For a standard FNA or core biopsy, a pathologist examines thin slices of tissue under a microscope, looking at cell shape, size, and organization. If the question is whether a cancer from elsewhere has spread to the node, this visual inspection alone is often enough.

If lymphoma is on the table, the workup gets more elaborate. A portion of the fresh tissue is sent for flow cytometry, a technique that passes individual cells through a laser one at a time, measuring surface markers that identify cell type. Flow cytometry can rapidly sort cells to determine whether there is an abnormal population suggestive of lymphoma. However, the combination of traditional microscopic examination with immunohistochemistry, a staining method that highlights specific proteins on cells in their intact tissue context, remains the gold standard for lymphoma diagnosis.¹³ In practice, pathologists often use both methods in parallel, sending part of the lymph node for flow cytometry and part for traditional staining, then cross-checking the results.¹⁴

How Diagnostic Accuracy Compares Across Methods

The question patients often ask is whether a needle biopsy is “good enough” or whether they really need surgery. The answer depends on the clinical situation. For detecting cancer that has metastasized to a lymph node from a known primary tumor, FNA and core needle biopsy are typically reliable. But for diagnosing and subtyping lymphoma, the gap between needle and surgical methods becomes meaningful.

One study comparing core needle biopsy to surgical excisional biopsy across 373 cases found that core needle biopsy reached a definitive diagnosis in about 79% of cases, compared to 97% for surgical excision. Most of the failures in the core needle group came down to insufficient or poor-quality tissue. The core needle approach did perform well for large B-cell lymphomas specifically.¹⁵ A separate single-center cohort found similar numbers, with a definitive lymphoma diagnosis achieved in about 74% of core needle cases versus 98% with surgical excision.¹⁶

This does not mean core needle biopsy is a poor choice. For many patients, especially those who are elderly or frail or who have nodes in surgically challenging locations, it is a reasonable first step. If the core needle sample is inconclusive, a surgical excision can follow. The two methods are more of a stepped approach than competitors.

Complications and Recovery

Lymph node biopsies are generally safe procedures, but the risk profile differs by method. FNA has the lowest complication rate: some bruising or tenderness at the site, rarely anything more. Core needle biopsy carries a small additional risk of bleeding, and local soreness typically fades within a day or two.

Surgical excisional biopsy involves a skin incision, so there is a brief recovery period with instructions to keep the wound clean and watch for signs of infection. Serious complications are uncommon in experienced surgical centers. Sentinel lymph node biopsy for melanoma has been studied in detail: among 339 patients in one series, the overall complication rate was about 6%. The most frequent issues were seroma, which is a pocket of fluid at the surgical site, nerve injury, and wound infection, each occurring in roughly 1% of patients. Lymphedema occurred in about half a percent of cases, and nearly all complications resolved over time, with the exception of one patient who developed chronic lymphedema of a lower limb.¹⁷

Pain management for surgical biopsies has evolved as well. For sentinel node biopsies done during breast-conserving surgery, regional nerve blocks performed at the end of surgery can significantly reduce the need for opioid pain medication afterward. These blocks use a local anesthetic deposited near the nerves supplying the surgical area, providing hours of pain relief as the patient wakes up from general anesthesia.¹⁸

Biopsies for Non-Cancer Conditions

Not every lymph node biopsy is about ruling out cancer. Lymph nodes swell in response to infections, autoimmune diseases, and inflammatory conditions, and sometimes a biopsy is the most direct path to a diagnosis. Sarcoidosis is a good example. This inflammatory disease causes clusters of immune cells, called granulomas, to form in various organs, and it often enlarges peripheral lymph nodes. In a study of 67 patients who had peripheral node biopsies for suspected sarcoidosis, the biopsy confirmed the diagnosis in the vast majority, with no procedure-related complications. The researchers concluded that when a patient suspected of having sarcoidosis has an enlarged peripheral lymph node, biopsy should be routine because it is easy to perform, inexpensive, and highly sensitive.¹⁹

Tuberculosis is another condition frequently diagnosed through lymph node biopsy, particularly in parts of the world where it is common. Granulomatous inflammation with characteristic necrosis in the tissue sample points the pathologist toward the diagnosis. Infectious causes more broadly, from cat-scratch disease to certain fungal infections, can all be identified when biopsied tissue is sent for culture and special stains alongside the standard microscopic examination.

Molecular Testing on Biopsy Samples

Pathology has moved well beyond looking at cells under a microscope. One of the more significant recent advances is the ability to run next-generation gene sequencing on the small amount of tissue obtained from a fine-needle aspiration. A study examining FNA samples from patients with non-Hodgkin lymphoma used an RNA-based assay targeting 125 genes to detect mutations and chromosomal translocations. Mutations or translocations were found in about a third of samples, and when results were compared between the FNA cytology sample and a matched surgical biopsy specimen, there was complete concordance in all eight paired cases tested.²⁰

This matters because it opens the door to getting detailed molecular information without requiring a full surgical biopsy. For patients who cannot undergo surgery or for nodes in hard-to-reach locations, having a molecular profile from just a needle sample can guide treatment decisions, especially in lymphomas where the specific genetic rearrangement determines which therapy is likely to work. The technology is still being validated more broadly, but the direction is clear: biopsy samples are getting smaller while the information extracted from them keeps growing.

How Long Results Take and What to Expect

Turnaround time varies widely depending on the type of biopsy and what tests are ordered. A straightforward FNA with on-site evaluation by a cytopathologist can give a preliminary answer within minutes, which is useful for triaging whether more tissue is needed. A standard surgical excisional biopsy processed with routine staining typically takes a few business days. If immunohistochemistry panels, flow cytometry, or molecular testing are added, the timeline extends, sometimes to one or two weeks.

The waiting period is often the hardest part for patients. It helps to know that a longer turnaround usually means the pathologist is being thorough, running additional tests to characterize the finding precisely. A lymphoma subtype diagnosis, for instance, can require correlation between microscopic appearance, protein-marker staining, flow cytometry, and sometimes genetic testing before the pathologist is confident enough to issue a final report. Your doctor typically will not share results until the full report is in, to avoid giving you incomplete or misleading information.

If you are scheduled for a lymph node biopsy, practical preparation is minimal for needle-based procedures. You may be asked to stop blood-thinning medications for a few days beforehand. For surgical biopsies, fasting instructions and anesthesia planning will depend on whether the procedure is done under local or general anesthesia. In most cases you can go home the same day, and the main aftercare instructions involve keeping the site clean, watching for excessive swelling or redness, and avoiding strenuous activity for a short period.